PharmaShots | Incisive News in 3 Shots

Subscribe Now

Alterations

Merck KGaA's Tepmetko (tepotinib) Receives the US FDA's Approval for Patients with Metastatic NSCLC with METex14 Skipping Alterations

Merck KGaA's Tepmetko (tepotinib) Receives the US FDA's Approval for Patients with Metastatic NSCLC with METex14 Skipping Alterati...

February 4, 2021

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us